Monsanto (MON) Earns News Impact Score of 0.11
Headlines about Monsanto (NYSE:MON) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Monsanto earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave media coverage about the basic materials company an impact score of 42.802019348928 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have impacted Accern’s analysis:
- Monsanto Company (MON) Earns “Buy” Rating from BMO Capital Markets (americanbankingnews.com)
- Monsanto Company (MON) Raised to “Buy” at Zacks Investment Research (americanbankingnews.com)
- Court documents reveal Monsanto edited “independent” scientific review (gmwatch.org)
- Monsanto (MON) versus American Vanguard Corporation (AVD) Head-To-Head Contrast (americanbankingnews.com)
- Monsanto wants national dicamba education (brownfieldagnews.com)
Several brokerages recently issued reports on MON. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. BMO Capital Markets reissued a “buy” rating and set a $128.00 target price on shares of Monsanto in a research note on Friday. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research note on Tuesday, June 27th. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a research note on Tuesday, August 29th. Finally, Jefferies Group LLC downgraded Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a research note on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $123.43.
Monsanto (NYSE:MON) traded up 0.01% during trading on Monday, hitting $117.21. The stock had a trading volume of 949,311 shares. The company has a market cap of $51.49 billion, a PE ratio of 25.32 and a beta of 1.07. Monsanto has a 12 month low of $97.35 and a 12 month high of $118.97. The company’s 50 day moving average is $117.18 and its 200-day moving average is $115.99.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. During the same quarter last year, the firm earned $2.17 earnings per share. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts predict that Monsanto will post $4.89 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. Monsanto’s dividend payout ratio is presently 46.75%.
In related news, EVP Steven Mizell sold 11,300 shares of the stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Janet M. Holloway sold 7,423 shares of the stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $118.00, for a total value of $875,914.00. Following the completion of the sale, the senior vice president now directly owns 33,645 shares of the company’s stock, valued at approximately $3,970,110. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,133 shares of company stock valued at $8,397,515. Insiders own 0.79% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Monsanto (MON) Earns News Impact Score of 0.11” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/05/monsanto-mon-earns-news-impact-score-of-0-11.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.